Código 300320 (Harmonized System 2012 by 6 digits)
2023: US$30.1M, Total Trade Exchange
2023: US$3.96M, International Sales
2023: US$26.1M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) was US$30.1M.
In 2023, the states with the most international sales in Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Ciudad de México (US$3.67M) and Jalisco (US$143k).
The states with the most international purchases in 2023 were Jalisco (US$17.5M) and Ciudad de México (US$8.39M).
In 2023, the main commercial destinations of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were India (US$2.62M), Morocco (US$1.02M), Nicaragua (US$78.9k), Guatemala (US$62.8k), and Bangladesh (US$28.4k).
The main commercial origins of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) in 2023 were China (US$18M), India (US$2.86M), Brazil (US$2.08M), Taiwan (Republic of China) (US$1.26M), and Puerto Rico (US$932k).
In the global context, the main exporting countries of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) in 2022 were China (US$289M), Italy (US$269M), and Jordan (US$44.6M). In the same year, the main importing countries of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Switzerland (US$210M), United States (US$57.1M), and Germany (US$47.2M).
US$30.1M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) in Mexico (including international purchases and sales) was US$30.1M.
The visualizations show the net balance of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024: US$2.31M, International Purchases
In November 2024, international sales of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were US$0, while international purchases reached US$2.31M. The above results in a trade balance of -US$2.31M.
Ciudad de México: US$3.67M, State with the Most International Sales (2023)
India: US$2.62M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Ciudad de México (US$3.67M) and Jalisco (US$143k).
In 2023, the countries with the most international purchases from Mexico were India (US$2.62M), Morocco (US$1.02M), Nicaragua (US$78.9k), Guatemala (US$62.8k), and Bangladesh (US$28.4k).
Jalisco: US$17.5M, State with the Most International Purchases (2023)
China: US$18M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Jalisco (US$17.5M) and Ciudad de México (US$8.39M).
The countries with the most international sales to Mexico in 2023 were China (US$18M), India (US$2.86M), Brazil (US$2.08M), Taiwan (Republic of China) (US$1.26M), and Puerto Rico (US$932k).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were China (US$289M), Italy (US$269M), and Jordan (US$44.6M). In the same year, the main importing countries for Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Switzerland (US$210M), United States (US$57.1M), and Germany (US$47.2M).